Company: HCWB
Filing Date: 2025-05-09
Form Type: S-1
Source: 0001193125-25-116745
Chunk: 83

Company: HCW Biologics Inc.
Filing Date: 2025-05-09
Form: S-1
Chunk 83
---
over provisions contained in our charter and bylaws, as well as provisions of Delaware law, could impair a takeover attempt. Our charter contains provisions that may discourage unsolicited takeover proposals that stockholders may consider to be in their best interests. We are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a change of control. Together, these provisions may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities. These provisions will include:

| • |     | no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect 
 director candidates;                                                                                          |

| • |     | the right of our Board to elect a director to fill a vacancy created by the expansion of our Board or the                                              
 resignation, death, or removal of a director in certain circumstances, which prevents stockholders from being able to fill vacancies on our Board; and |

| • |     | a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual 
 or special meeting of our stockholders.                                                                          |

Our charter provides that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees. Our charter provides that, subject to limited exceptions, any (i) derivative action or proceeding brought on our behalf of under Delaware law, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer or other employee of HCWB’s stockholders, (iii) any action asserting a claim against HCWB or any of its directors, officers or other employees arising pursuant to any provision of the DGCL, the charter or the bylaws of HCWB (in each case, as may be amended from time to time), (iv) any action asserting a claim against HCWB or any of its directors, officers or other employees governed by the internal affairs doctrine of the State of Delaware or (v) any other action asserting an “internal corporate claim,” as defined in Section 115 of the DGCL, in all cases subject to the court’s having personal jurisdiction over all indispensable parties named as defendants shall, to the fullest extent permitted by law, be exclusively brought in the Court of Ch